H Esterbauer
Overview
Explore the profile of H Esterbauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
6250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolff F, Loipetzberger A, Gruber W, Esterbauer H, Aberger F, Frischauf A
Oncogene
. 2013 Sep;
32(50):5574-81.
PMID: 23995793
Imiquimod (IMQ), a nucleoside analogue of the imidazoquinoline family, is used in the topical treatment of basal cell carcinoma (BCC) and other skin diseases. It is reported to be a...
2.
Ehses J, Meier D, Wueest S, Rytka J, Boller S, Wielinga P, et al.
Diabetologia
. 2010 Apr;
53(8):1795-806.
PMID: 20407745
Aims/hypothesis: Inflammation contributes to both insulin resistance and pancreatic beta cell failure in human type 2 diabetes. Toll-like receptors (TLRs) are highly conserved pattern recognition receptors that coordinate the innate...
3.
Wohrer S, Rabitsch W, Shehata M, Kondo R, Esterbauer H, Streubel B, et al.
Anticancer Res
. 2008 Jan;
27(6B):3837-41.
PMID: 18225540
Background: Human mesenchymal stem cells (MSCs) are thought to be multipotent cells which primarily reside in the bone marrow. Besides their well-known ability to replicate as undifferentiated cells and to...
4.
Sillaber C, Mayerhofer M, Bohm A, Vales A, Gruze A, Aichberger K, et al.
Eur J Clin Invest
. 2008 Jan;
38(1):43-52.
PMID: 18173550
Background: Recent data suggest that the mammalian target of rapamycin (mTOR) is involved in the regulation of growth of neoplastic cells in chronic myeloid leukaemia (CML). Patients And Methods: We...
5.
Agis H, Sperr W, Herndlhofer S, Semper H, Pirc-Danoewinata H, Haas O, et al.
Ann Oncol
. 2007 Sep;
18(11):1834-41.
PMID: 17804468
Background: Although imatinib is highly effective in chronic myeloid leukemia (CML), drug-resistance may occur. Therefore, monitoring of minimal residual disease (MRD) during treatment with imatinib is important. However, most MRD-parameters...
6.
Aichberger K, Herndlhofer S, Agis H, Sperr W, Esterbauer H, Rabitsch W, et al.
Eur J Clin Invest
. 2007 Aug;
37(10):808-13.
PMID: 17727673
Background: Central nervous system (CNS) relapse in chronic myeloid leukaemia (CML) is rare and if recorded is usually found to occur in patients with lymphoblastic transformation. The BCR/ABL tyrosine kinase...
7.
Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, SANDHOFER F, et al.
Nat Genet
. 2001 May;
28(2):178-83.
PMID: 11381268
Obesity is the most common nutritional disorder in Western society. Uncoupling protein-2 (UCP2) is a recently identified member of the mitochondrial transporter superfamily that is expressed in many tissues, including...
8.
Wonisch W, Zellnig G, Kohlwein S, Schaur R, Bilinski T, Tatzber F, et al.
Cell Biochem Funct
. 2001 Feb;
19(1):59-64.
PMID: 11223872
No abstract available.
9.
Patsch W, Esterbauer H, Foger B, Patsch J
Curr Atheroscler Rep
. 2000 Dec;
2(3):232-42.
PMID: 11122749
A number of cross-sectional studies have demonstrated that the magnitude of postprandial lipemia or single postprandial triglyceride values predict asymptomatic and symptomatic atherosclerosis, independent of risk factors measured in the...
10.
Oberkofler H, Neschen S, Esterbauer H, Waldhausl W, Patsch W, Furnsinn C
Biochim Biophys Acta
. 2000 Dec;
1517(1):113-8.
PMID: 11118623
Uncoupling protein-3 (UCP3), a mitochondrial carrier protein predominantly expressed in muscle, has been suggested to release stored energy as heat. The insulin-sensitizing thiazolidinediones enhance glucose disposal in skeletal muscle and...